Skip to main content

Table 1 Summary of samples taken for antimicrobial resistance analysis

From: Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial

Duration of intervention in community

Child age in months

Biological specimen

Storage media

Estimated number of aliquots

Storage temperature

Number of children

0 months

4–14 and 49–59

Nasopharyngeal swab

STGG media

2

−80°

1350 + 1350

0 months

4–14 and 49–59

Rectal swab

Cary-Blair media

1

−80°

1350 + 1350

0 months

4–14 and 49–59

Rectal swab

DESS media

1

−80°

1350 + 1350

0 months

4–14 and 49–59

Rectal swab

None, stored dry

1

−80°

1350 + 1350

12 months

4–14 and 49–59

Nasopharyngeal swab

STGG media

2

−80°

1350 + 1350

12 months

4–14 and 49–59

Rectal swab

Cary-Blair media

1

−80°

1350 + 1350

12 months

4–14 and 49–59

Rectal swab

DESS media

1

−80°

1350 + 1350

12 months

4–14 and 49–59

Rectal swab

None, stored dry

1

−80°

1350 + 1350

24 months

4–14 and 49–59

Nasopharyngeal swab

STGG media

2

−80°

1350 + 1350

24 months

4–14 and 49–59

Rectal swab

Cary-Blair media

1

−80°

1350 + 1350

24 months

4–14 and 49–59

Rectal swab

DESS Media

1

−80°

1350 + 1350

24 months

4–14 and 49–59

Rectal swab

None, stored dry

1

−80°

1350 + 1350

36 months post-baseline

4–14 and 49–59

Nasopharyngeal swab

STGG media

2

−80°

1350 + 1350

36 months post-baseline

4–14 and 49–59

Rectal swab

Cary-Blair media

1

−80°

1350 + 1350

36 months post-baseline

4–14 and 49–59

Rectal swab

DESS media

1

−80°

1350 + 1350

36 months post-baseline

4–14 and 49–59

Rectal swab

None, stored dry

1

−80°

1350 + 1350

  1. STGG, skim milk-tryptone-glucose-glycerin; DESS, dimethyl sulfoxide, ethylenediamine tetraacetic acid, saturated salt